PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy

Koji Matsumoto, Meiko Nishimura, Takuma Onoe, Hideki Sakai, Yusaku Urakawa, Takashi Onda, Nobuo Yaegashi

研究成果: ジャーナルへの寄稿 › 総説 › 査読